These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
143 related items for PubMed ID: 8717073
21. Long-term follow-up after partial removal of a solitary kidney. Novick AC, Gephardt G, Guz B, Steinmuller D, Tubbs RR. N Engl J Med; 1991 Oct 10; 325(15):1058-62. PubMed ID: 1891007 [Abstract] [Full Text] [Related]
22. Selective lymphocyte inhibition by FTY720 slows the progressive course of chronic anti-thy 1 glomerulosclerosis. Peters H, Martini S, Wang Y, Shimizu F, Kawachi H, Krämer S, Neumayer HH. Kidney Int; 2004 Oct 10; 66(4):1434-43. PubMed ID: 15458436 [Abstract] [Full Text] [Related]
31. Influence of dietary protein/calorie intake on renal morphology and function in cats with 5/6 nephrectomy. Adams LG, Polzin DJ, Osborne CA, O'Brien TD, Hostetter TH. Lab Invest; 1994 Mar 10; 70(3):347-57. PubMed ID: 8145529 [Abstract] [Full Text] [Related]
33. Successful Treatment With Abatacept in Recurrent Focal Segmental Glomerulosclerosis After Kidney Transplant. Shah Y, Almeshari K, Aleid H, Broering D, Alahmadi I, Ali T. Exp Clin Transplant; 2019 Jan 10; 17(Suppl 1):178-180. PubMed ID: 30777550 [Abstract] [Full Text] [Related]
34. [Idiopathic collapsing glomerulopathy in children: report of two cases]. Wei RG, Chen SM, Jiang T, Jiang XY, Zeng Y, Mo Y. Zhonghua Er Ke Za Zhi; 2004 Oct 10; 42(10):731-3. PubMed ID: 16221337 [Abstract] [Full Text] [Related]
35. Primary focal segmental glomerulosclerosis: clinical course, predictors of renal outcome and treatment. Shiiki H, Dohi K. Intern Med; 2000 Aug 10; 39(8):606-11. PubMed ID: 10939532 [Abstract] [Full Text] [Related]
38. The development of proteinuria and focal-segmental glomerulosclerosis in recipients of pediatric donor kidneys. Hayes JM, Steinmuller DR, Streem SB, Novick AC. Transplantation; 1991 Nov 10; 52(5):813-7. PubMed ID: 1949166 [Abstract] [Full Text] [Related]
39. Renoprotective effects of combined endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 in acute and chronic experimental renal damage. Sharkovska Y, Kalk P, von Websky K, Relle K, Pfab T, Alter M, Fischer Y, Hocher B. Clin Lab; 2011 Nov 10; 57(7-8):507-15. PubMed ID: 21888014 [Abstract] [Full Text] [Related]
40. Lipids and the progression of renal disease. Keane WF, O'Donnell MP, Kasiske BL, Schmitz PG. J Am Soc Nephrol; 1990 Nov 10; 1(5 Suppl 2):S69-74. PubMed ID: 16989069 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]